SCHEMBL4011711

SCHEMBL4011711

CCCC[Ge](CCCC)(C(=O)c1ccccc1)C(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 5/20 0.50
▸ CES1 P23141 5/20 0.50
▸ PTGS2 P35354 2/20 0.47
▸ NAAA Q02083 1/20 0.46
▸ LMNA P02545 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.41
▸ ESR1 P03372 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ PARP1 P09874 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4019838 0.88 CES1 (0.47) CES2CES1PTGS2NAAALMNA
SCHEMBL4953798 0.81 CES2 (0.47) CES2CES1PTGS2NAAALMNA
SCHEMBL274249 0.79 CES1 (0.48) CES2CES1LMNAALDH1A1POLB
Bromomethane SCHEMBL30082988 0.76 CES1 (0.45) CES2CES1LMNAALDH1A1POLB
Benzamide SCHEMBL28124928 0.74 CYP3A4 (0.70) CES2CES1NAAALMNAPOLB
Benzamide SCHEMBL22117133 0.74 CYP3A4 (0.70) CES2CES1PTGS2NAAALMNA
Benzophenone SCHEMBL23014697 0.73 ALDH1A1 (0.67) CES2CES1NAAALMNAALDH1A1
Benzoic Acid SCHEMBL28845500 0.73 TSHR (0.67) CES2CES1NAAAALDH1A1MAPT
Benzoic Acid SCHEMBL6573567 0.73 TSHR (0.67) CES2CES1NAAAALDH1A1TSHR
Benzoic Acid SCHEMBL9157936 0.73 TSHR (0.67) CES2CES1NAAAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3119377-B1 PHOTOPOLYMERISABLE AND DUAL HARDENING DENTAL MATERIAL BASED ON THIOUREA DERIVATIVES AND BISACYLDIALKYLGERMANIUM-COMPOUNDS IVOCLAR VIVADENT AG (LI) 2021-12-29 — — EP claimed
CN-106132380-B Photopolymerizable dual-cure dental materials based on thiourea derivatives 义获嘉伟瓦登特公司 2020-02-11 — — CN claimed
EP-2921156-B1 Monomer mixture for the preparation of dental materials IVOCLAR VIVADENT AG (LI) 2019-10-02 — — EP claimed
US-10195121-B2 Photopolymerizable and dual-curing dental materials based on thiourea derivatives IVOCLAR VIVADENT AG (LI) 2019-02-05 — — US claimed
US-10130562-B2 Monomer mixture for the preparation of dental materials IVOCLAR VIVADENT AG (LI) 2018-11-20 — — US claimed
US-20170143592-A1 MONOMER MIXTURE FOR THE PREPARATION OF DENTAL MATERIALS IVOCLAR VIVADENT AG (LI) 2017-05-25 — — US claimed
US-20170128328-A1 Photopolymerizable and dual-curing dental materials based on thiourea derivatives IVOCLAR VIVADENT AG (LI) 2017-05-11 — — US claimed
EP-2921154-B1 Photopolymerisable and dual hardening dental material based on thiourea derivatives and bisacyldialkylgermanium-compounds IVOCLAR VIVADENT AG (LI) 2017-03-08 — — EP claimed
EP-3119377-A1 PHOTOPOLYMERISABLE AND DUAL CURING DENTAL MATERIALS BASED ON THIOUREA DERIVATIVES Ivoclar Vivadent AG (LI) 2017-01-25 — — EP claimed
WO-2015139811-A1 MONOMER MIXTURES FOR PRODUCING DENTAL MATERIALS IVOCLAR VIVADENT AG (LI) 2015-09-24 — — WO claimed
WO-2015140276-A1 PHOTOPOLYMERISABLE AND DUAL CURING DENTAL MATERIALS BASED ON THIOUREA DERIVATIVES IVOCLAR VIVADENT AG (LI) 2015-09-24 — — WO claimed
EP-2921156-A1 Monomer mixture for the preparation of dental materials Ivoclar Vivadent AG (LI) 2015-09-23 — — EP claimed
EP-2921154-A1 Photopolymerisable and dual hardening dental material based on thiourea derivatives and bisacyldialkylgermanium-compounds Ivoclar Vivadent AG (LI) 2015-09-23 — — EP claimed
EP-4717249-A1 DENTAL COMPOSITION Shofu Inc. (JP) 2026-04-01 — — EP disclosed
US-20260083642-A1 DENTAL COMPOSITION SHOFU INC (JP) 2026-03-26 — — US disclosed
US-20260060900-A1 DENTAL COMPOSITE RESIN KIT SHOFU INC. (JP) 2026-03-05 — — US disclosed
US-20080277814-A1 Polymerizable compositions with acylgermanium compounds IVOCLAR VIVADENT AG (LI) 2008-11-13 — — US disclosed
EP-1905413-A1 Polymerisable compositions comprising acyl-germanium as initiators Ivoclar Vivadent AG (LI) 2008-04-02 — — EP disclosed
EP-1905415-A1 Polymerisable compositions comprising acyl-germanium as initiators IVOCLAR AG (LI) 2008-04-02 — — EP disclosed
US-20080076847-A1 Polymerizable compositions with acylgermanes as initiatiors IVOCLAR VIVADENT AG (LI) 2008-03-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260060900-A1 DENTAL COMPOSITE RESIN KIT BOLA2; BOLA2B, LBR, COL2A1 CES2 578/4885CES1 451/4885PTGS2 799/4885
US-20080076847-A1 Polymerizable compositions with acylgermanes as initiatiors NR1I3, NR4A1, NR1I2 CES2 1371/4885CES1 548/4885PTGS2 1703/4885
US-20260083642-A1 DENTAL COMPOSITION TAS2R42, COL2A1, TAS2R1 CES2 416/4885CES1 1600/4885PTGS2 864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback